Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Ocular Therapeutix, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 5 filings
- 5 insiders, $333.1K in total
- Insiders trading
- 5
- Net value
- −$333.1K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Ocular Therapeutix, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Notman Donald | Chief Operating Officer | 366,529 | Sep 2, 2026 | 4 |
| Kaiser Peter | Chief Development Officer | 264,378 | Aug 26, 2026 | 6 |
| Nayak Sanjay | Chief Strategy Officer | 326,898 | Aug 26, 2026 | 6 |
| Heier Jeffrey S. | Chief Scientific Officer | 318,326 | Aug 26, 2026 | 6 |
| Dugel Pravin | See Remarks | 744,903Indirect | Aug 26, 2026 | 7 |
| Raines Merilee | Director | 60,933 | Jun 12, 2026 | 1 |
| Lindstrom Richard L MD | Director | 260,933 | Jun 12, 2026 | 2 |
| Graves Adrienne L | Director | 64,000 | Jun 12, 2026 | 1 |
| Warden Charles M | Director | 100,464 | Jun 12, 2026 | 1 |
| Williams Leslie J. | Director | 65,433 | Jun 12, 2026 | 1 |
| Hong Seung Suh | Director | 60,933 | Jun 12, 2026 | 1 |
| Robins Jason Shand | Chief Financial Officer | 68,097 | Jun 12, 2026 | 2 |
| Waheed Nadia | Chief Medical Officer | 300,079 | Jun 5, 2026 | 4 |
| Robinson David Wayne | Global CCO | 136,000 | Jan 26, 2026 | 1 |
| Anderman Todd | Chief Legal Officer | 152,468 | Jan 6, 2026 | 2 |
| Saroj Namrata | Chief Business Officer | 254,620 | Jan 6, 2026 | 2 |
| Meyers Steve Lawrence | Chief Commercial Officer | 217,628 | Jan 6, 2026 | 1 |
| Summer Road LLC | 10% Owner | 8,591,401Indirect | Feb 27, 2024 | 0 |
| White Christopher G | Chief Business Officer | 123,689 | Feb 6, 2024 | 0 |
| Mattessich Antony C. | President and CEO | 588,701 | Feb 6, 2024 | 0 |
| Ozden Rabia Gurses | Chief Medical Officer | 153,054 | Feb 6, 2024 | 0 |
| Strassburger Philip C. | General Counsel | 161,493 | Feb 6, 2024 | 0 |
| Goldstein Michael H. | President, Ophthalmology & CMO | 313,335 | Feb 7, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2024 (view filing) | Aug 23 | 4 days | Dugel PravinSee Remarks | SSale | −20.9K | $9.02 | −$188.3K | −2.5%812.5K after | 10b5-1 |
| May 28, 2024 (view filing) | May 23 | 5 days | Nayak SanjayChief Strategy Officer | SSale | −2.27K | $5.84 | −$13.3K | −1.3%178.0K after | 10b5-1 |
| May 28, 2024 (view filing) | May 23 | 5 days | Dugel PravinSee Remarks | SSale | −21.6K | $5.79 | −$125.2K | −2.5%833.4K after | 10b5-1 |
| Feb 27, 2024 (view filing) | Feb 26 | 1 day | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +930.9K | $7.52 | +$7.00M | +12.2%8.59M after | |
| Feb 6, 2024 (view filing) | Feb 5 | 1 day | White Christopher GChief Business Officer | SSale | +5.91K | $4.86 | +$28.7K | +5.0%123.7K after | |
| Feb 6, 2024 (view filing) | Feb 5 | 1 day | Strassburger Philip C.General Counsel | SSale | +6.03K | $4.86 | +$29.3K | +3.9%161.5K after | |
| Feb 6, 2024 (view filing) | Feb 5 | 1 day | Ozden Rabia GursesChief Medical Officer | SSale | +6.35K | $4.86 | +$30.8K | +4.3%153.1K after | |
| Feb 6, 2024 (view filing) | Feb 5 | 1 day | Notman DonaldChief Financial Officer | SSale | +6.21K | $4.86 | +$30.2K | +3.3%195.4K after | |
| Feb 6, 2024 (view filing) | Feb 5 | 1 day | Mattessich Antony C.President and CEO | SSale | +19.6K | $4.86 | +$95.5K | +3.5%588.7K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Notman DonaldChief Financial Officer | SSale | −6.43K | $4.95 | −$31.8K | −4.4%139.9K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Ozden Rabia GursesChief Medical Officer | SSale | −7.76K | $4.95 | −$38.4K | −7.7%92.8K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Strassburger Philip C.General Counsel | SSale | −6.83K | $4.95 | −$33.8K | −5.9%109.2K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | White Christopher GChief Business Officer | SSale | −5.15K | $4.95 | −$25.5K | −5.4%89.6K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Mattessich Antony C.President and CEO | SSale | −18.3K | $4.95 | −$90.8K | −4.1%427.9K after | |
| Dec 18, 2023 (view filing) | Dec 14 | 4 days | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +1.54M | $3.25 | +$5.00M | +25.1%7.66M after | |
| Sep 5, 2023 (view filing) | Aug 30 | 6 daysLate | Mattessich Antony C.President and CEO | PPurchase | +6.50K | $3.81 | +$24.8K | New position6.50K after | |
| Jul 11, 2023 (view filing) | Jul 7 | 4 days | Ozden Rabia GursesChief Medical Officer | SSale | −832 | $4.93 | −$4.10K | −0.8%100.5K after | |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | White Christopher GChief Business Officer | SSale | −5.83K | $4.24 | −$24.7K | −5.8%94.8K after | |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | Ozden Rabia GursesChief Medical Officer | SSale | −6.42K | $4.24 | −$27.2K | −6.0%101.4K after | |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | Notman DonaldChief Financial Officer | SSale | −6.48K | $4.24 | −$27.5K | −4.4%139.4K after | |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | Strassburger Philip C.General Counsel | SSale | −6.18K | $4.24 | −$26.2K | −5.4%109.1K after | |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | Mattessich Antony C.President and CEO | SSale | −19.7K | $4.24 | −$83.4K | −4.2%446.3K after | |
| Nov 9, 2022 (view filing) | Nov 7 | 2 days | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +7.33K | $3.50 | +$25.6K | +0.1%6.12M after | |
| Oct 12, 2022 (view filing) | Oct 10-11 | 2 days | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +20.0K | $3.95 | +$79.0K | +0.3%6.11M after | 2 lots |
| Sep 29, 2022 (view filing) | Sep 27-29 | 2 days | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +150.0K | $4.60 | +$689.3K | +2.5%6.09M after | 3 lots |
| May 16, 2022 (view filing) | May 12 | 4 days | Heier Jeffrey S.Director | PPurchase | +15.0K | $3.05 | +$45.8K | +62.5%39.0K after | |
| Feb 23, 2022 (view filing) | Feb 18-23 | 5 days | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +50.0K | $4.96 | +$248.0K | +0.8%5.94M after | 2 lots |
| Jan 31, 2022 (view filing) | Jan 27-28 | 4 days | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +5.50K | $5.20 | +$28.6K | +0.1%5.89M after | 2 lots |
| Jan 24, 2022 (view filing) | Jan 20-24 | 4 days | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +74.5K | $5.44 | +$405.6K | +1.3%5.89M after | 3 lots |
| Jan 18, 2022 (view filing) | Jan 13-18 | 5 days | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +50.0K | $6.06 | +$303.0K | +0.9%5.81M after | 3 lots |
| Dec 16, 2021 (view filing) | Dec 14-15 | 2 days | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +44.5K | $6.35 | +$282.3K | +0.8%5.76M after | 2 lots |
| Dec 14, 2021 (view filing) | Dec 10-13 | 4 days | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +40.5K | $6.61 | +$267.8K | +0.7%5.72M after | 2 lots |
| Dec 8, 2021 (view filing) | Dec 6-8 | 2 days | Summer Road LLC10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +60.9K | $6.18 | +$376.6K | +1.1%5.68M after | 2 lots |
| Aug 24, 2021 (view filing) | Aug 20 | 4 days | Mattessich Antony C.President and CEO | PPurchase | +5.00K | $9.89 | +$49.5K | +5.1%102.9K after |